EUVIMEDEUVIMED entdecken
Crossref

Research Progress of Novel Inflammatory Markers in Lung Cancer: From NLR, PLR to SII

彦西 姚

Advances in Clinical Medicine · 2026 · 16 (03) · 3184-3192

DOI: 10.12677/acm.2026.1631124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 彦西 姚. Die Arbeit nennt 45 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

姚, 彦. (2026). Research Progress of Novel Inflammatory Markers in Lung Cancer: From NLR, PLR to SII. Advances in Clinical Medicine, 16(03), 3184-3192. https://doi.org/10.12677/acm.2026.1631124

Vancouver

姚 彦. Research Progress of Novel Inflammatory Markers in Lung Cancer: From NLR, PLR to SII. Advances in Clinical Medicine. 2026;16(03):3184-3192. doi:10.12677/acm.2026.1631124

BibTeX
@article{2026,
  author = {姚, 彦西},
  title = {Research Progress of Novel Inflammatory Markers in Lung Cancer: From NLR, PLR to SII},
  journal = {Advances in Clinical Medicine},
  year = {2026},
  volume = {16},
  number = {03},
  pages = {3184--3192},
  doi = {10.12677/acm.2026.1631124}
}
Kostenlos starten →